AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "cg1111-screening-for-downs-edwards-and-pataus-syndrome-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 1330
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "Screening for Down’s, Edward’s, and Patau’s Syndromes",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "NICE",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "I cannot find a publication year in the provided text. The guideline text does not explicitly mention a 4-digit year",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary:** This guideline outlines screening for Down’s (T21), Edward’s (T18), and Patau’s (T13) syndromes. Key recommendations: - **Screening Offer:** NIPT (non-invasive prenatal testing) is offered after a higher-chance result from combined/quadruple tests. Options include no further testing, NIPT, or prenatal diagnosis. - **Timing:** Testing available up to 21+6 weeks, with results expected within 2 weeks. - **Results:** Reported as lower or higher chance. Samples may be retained for quality assurance. - **Eligibility:** Includes IVF and donor egg pregnancies. - **Follow-Up:** Clear referral pathways for abnormal results. - **Staff Requirements:** Midwives must undergo specific education/training. - **Consent & Care:** Emphasizes informed decision-making, timely results, and optimal management for confirmed diagnoses. - **Audit:** Monitoring processes ensure guideline adherence. Targets all involved staff, ensuring standardized screening and care",
      "action": "added"
    }
  ]
}